Clinical Trial Update: SMART Design to Compare Antipsychotic Treatments in Treatment-Resistant Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 trial design update comparing antipsychotic treatments for treatment-resistant schizophrenia; status and full results are not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Treatment-resistant Schizophrenia

Snippet

Sponsor: Shanghai Mental Health Center | Conditions: Treatment-resistant Schizophrenia | Phase 3 | Status: UNKNOWN